Inhibition of p38 kinase activity by aryl ureas

US6344476B1 · kind B1 · utility

Assignee

• BAYER HEALTHCARE LLC · DE

Inventors

• Gerald Ranges · Hamden, US
• William Scott · Guilford, US
• Michael Bombara · Hamden, US
• Deborah Rauner · Sandy Hook, US
• Aniko Redman · Derby, US
• Roger Smith · Madison, US
• Holger Paulsen · Wuppertal, DE
• David Gunn · Waukegan, US
• Jinshan Chen · Madison, US
• Joel Renick · San Diego, US

Key dates

• Filing date: May 22, 1998
• Grant date: Feb 5, 2002
• Expiry date: May 22, 2018

Classification

• Technology area (CPC Y): Emerging Cross-Sectional Technologies
• CPC primary: Y02A50/30
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

This invention relates to the use of a group of aryl ureas in treating cytokine mediated diseases other than cancer and proteolytic enzyme mediated diseases other than cancer, and pharmaceutical compositions for use in such therapy.